Reg joined The Braff Group in 2006 as a Managing Director focused on transactions in the home infusion, specialty pharmacy, and institutional pharmacy markets. He has over 25 years experience in the medical industry as a senior executive in both the home care and medical device sectors. Prior to The Braff Group, he was Vice President of Business Development and VP of Sales/Marketing for Proxima Therapeutics, a venture capital backed company with a novel cancer treatment technology. He was instrumental in building the company through its various stages including product development, FDA clinical study, commercial launch and eventual sale of the company for $190 million. Earlier in his career he was responsible for establishing over 20 home infusion and chemotherapy facilities throughout the United States. At McGaw Laboratories, an intravenous products company, he was Director of Sales for the homecare market. In addition, he was Vice President of Sales for Gesco Corporation, the market leader in peripherally inserted central venous catheters (PICC), which was sold to C.R. Bard Corporation.
Reg earned his Bachelor of Science in Business from Wake Forest University and his MBA from Temple University.
